EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Loss of LCN2 Function Ameliorates Glucocorticoid‐Induced Muscle Atrophy via Remodeling the Extracellular Matrix

Hongwei Shi, Xiaojing Hao, Yi Yan, Fengyang Li iD, Yaru Zhang, Zixin Li, Wenjuan Xie, Jiayin Lu iD, Xiaomao Luo, Yanjun Dong iD, Haidong Wang iD, Juan Wang

Advanced Science · 2026-11 · 13 (62)

DOI: 10.1002/advs.77189 ↗

At a glance

Journal article in Advanced Science, published online on 2026-08-18. Written by Hongwei Shi and 11 co-authors. Institution: College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, Shanxi, People's Republic of China. Major MEDLINE topics: Lipocalin-2, Extracellular Matrix, Muscular Atrophy, Glucocorticoids. 42 references. The full text is freely available (open access, CC BY 4.0). Funded by: Sanjin Talents Support Program of Shanxi Province, Shanxi Key Laboratory of Animal Disease Research, Prevention and Control, College of Veterinary Medicine, Shanxi Agricultural University, fundamental Research Program of Shanxi Province Graduate Education Innovation Programme.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Chronic glucocorticoid (GC) exposure is the leading clinical cause of skeletal muscle atrophy, steroid myopathy, and secondary sarcopenia, triggering irreversible motor function decline, disease progression, and elevated all‐cause mortality. The underlying pathological mechanisms remain unclear, and no safe and effective targeted interventions are currently available. This study identifies Lipocalin 2 (LCN2) as a pivotal driver of GC‐induced muscle atrophy. Using multi‐omics analysis, dexamethasone‐induced mouse models, primary myotube models, and gain/loss‐of‐function assays, we found that LCN2 was the most strikingly upregulated factor in atrophic muscle, and that its transcription was directly activated by glucocorticoid receptor (GR) binding to the conserved glucocorticoid response element (GRE) in its promoter. Muscle‐specific LCN2 overexpression disrupts extracellular matrix (ECM) homeostasis and triggers severe muscle atrophy and motor dysfunction, whereas LCN2 silencing markedly alleviates GC‐induced ECM injury and atrophy without impairing normal muscle homeostasis. Mechanistically, the interaction of LCN2 with matrix metalloproteinase 9 (MMP9) triggers ECM dysregulation and consequent focal adhesion kinase (FAK) signaling inactivation, which represses the PI3K‐Akt‐mTOR anabolic cascade and activates FoxO‐driven catabolic signaling, thereby leading to dysregulated muscle protein metabolism. This study reveals the core pathogenic role of the LCN2‐MMP9‐ECM‐FAK axis in GC‐induced muscle atrophy, providing a promising novel therapeutic target for steroid myopathy.

Subjects

MeSH terms (MEDLINE)

Lipocalin-2Extracellular MatrixMuscular AtrophyGlucocorticoidsAnimalsMiceDisease Models, AnimalMatrix Metalloproteinase 9Muscle, SkeletalMaleSignal Transduction

Author keywords

Lipocalin 2MMP9extracellular matrixglucocorticoid receptormuscle atrophy

Substances

Lipocalin-2GlucocorticoidsLcn2 protein, mouseMatrix Metalloproteinase 9

Authors and institutions

  • College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, Shanxi, People's Republic of China.
  • College of Veterinary Medicine, China Agricultural University, Beijing, People's Republic of China.
  • Department of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.

ORCID profiles: Fengyang Li, Jiayin Lu, Yanjun Dong, Haidong Wang

Funding

  • Sanjin Talents Support Program of Shanxi Province
  • Shanxi Key Laboratory of Animal Disease Research, Prevention and Control, College of Veterinary Medicine, Shanxi Agricultural University
  • fundamental Research Program of Shanxi Province Graduate Education Innovation Programme
  • Shanxi Veterinary Pharmaceutical lndustry Technology lnnovation Research Institute (lndustrial College)
  • Shanxi Veterinary Pharmaceutical Industry Technology Innovation Strategic Alliance
  • Research Project Supported by Shanxi Scholarship Council of China
  • Young Science & Technology Leadership Program
  • Fundamental Research Program of Shanxi Province

Cite

APA

Shi, H., Hao, X., Yan, Y., Li, F., Zhang, Y., Li, Z., Xie, W., Lu, J., Luo, X., Dong, Y., Wang, H., & Wang, J. (2026). Loss of LCN2 Function Ameliorates Glucocorticoid‐Induced Muscle Atrophy via Remodeling the Extracellular Matrix. Advanced Science, 13(62). https://doi.org/10.1002/advs.77189

Vancouver

Shi H, Hao X, Yan Y, Li F, Zhang Y, Li Z, et al. Loss of LCN2 Function Ameliorates Glucocorticoid‐Induced Muscle Atrophy via Remodeling the Extracellular Matrix. Advanced Science. 2026;13(62). doi:10.1002/advs.77189

BibTeX
@article{Shi2026,
  author = {Shi, Hongwei and Hao, Xiaojing and Yan, Yi and Li, Fengyang and Zhang, Yaru and Li, Zixin and Xie, Wenjuan and Lu, Jiayin and Luo, Xiaomao and Dong, Yanjun and Wang, Haidong and Wang, Juan},
  title = {Loss of LCN2 Function Ameliorates Glucocorticoid‐Induced Muscle Atrophy via Remodeling the Extracellular Matrix},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {62},
  doi = {10.1002/advs.77189}
}
Start for free →